In order to increase the knowledge of its employees in the field of “orphan drugs”, ClinTriCare invited one of the leading experts in this field to speak at a training event. Due to his many years of experience, the speaker was able to exemplify the theoretical knowledge with impressive real-life cases.

He pointed out that competent networks, trained physicians and well-equipped competence centers allow for better treatment of patients with very rare diseases.